News Imprimis Receives FDA Warning Over Eye Medication Advertising by Medscape • 2018/01/17 • 0 Comments The U.S. Food and Drug Administration has issued a warning letter to Imprimis Pharmaceuticals Inc accusing it of making false or misleading claims that its compounded eye medications had the agency's approval. Reuters Health Information Full Story →